LATEST ALERTS
No food item should contain any cannabinoid, including CBD, in the EU without prior novel food ingredient authorisation following a change by European authorities – though this is open to interpretation
Researchers in Portugal have developed an algorithm to identify characteristics that suggest the nations most likely to legalise recreational cannabis
An unconfirmed seizure of products from a shop in Arizona could be the first instance of enforcement on CBD by Food and Drug Administration (FDA) officials since the passage of the US 2018 Farm Bill
Mexico may well become the third country in the world to fully legalise all cannabis products, including marijuana. In the meantime, CBD and hemp-containing products are allowed as long as they contain less than 1% THC
The Canadian government has released proposed regulations for additional products containing cannabis-derived ingredients, including food items, beverages, extracts and topicals
The US Congress is expected to address the legal situation of CBD and cannabis during the upcoming congressional session, according to a number of experts interviewed by CBD-Intel
Pro-cannabis measures are expected to receive at least 18 more votes of support in the new US Congress, according to exclusive research by CBD-Intel, with more than 60 new Representatives supporting legalisation
While CBD has been one of THE stories of 2018, the novelty phase is now over, and 2019 will be the year the longer-term future of CBD products becomes clearer. CBD-Intel looks at prospects for the months ahead
Removing hemp from the federal narcotics Schedule 1 list does not mean that all CBD products are now permitted, the US Food and Drug Administration (FDA) has warned
The US Congress has approved a compromise version of the 2018 Farm Bill which will remove industrial hemp from the federal narcotics Schedule 1 list, potentially giving a green light to development of the CBD industry
In our latest regulatory snapshot, we look at Austria where in general the extraction and manufacture of CBD is allowed and hemp can be grown as long as the variety is on some of the key approved lists
Securing cannabis supplies for research purposes is the focus of an information request from the US federal government. They are asking businesses about the ability to analyse, produce, and even distribute cannabis products for research. The National Institute on Drug Abuse (NIDA) is probing for businesses that have the “in-house capability to act as a centralized source for acquisition and/or production, analysis, and distribution of cannabis and related materials for research purposes,” according to a federal notice.
The British government last week presented the 585-page draft withdrawal agreement which lays out how it intends the UK to leave the European Union. Here CBD-Intel explains just how it may affect the CBD industry
In our latest look at Poland, we find that THC is a regulated substance, thus all the products on the market which have not obtained a medical authorisation must be THC-free
In our overview of the regulatory landscape in the United Kingdom we find that while the UK is one of Europe’s largest CBD markets, growing and extracting CBD is restricted and there is a zero-tolerance policy for THC content in CBD products
A founder of the UK Cannabis Trades Association (CTA) has resigned, alleging the industry body has been misleading companies about its role in regulation
Despite being Europe’s biggest hemp grower and reputedly its highest cannabis user, France has one of Europe’s most restrictive regulatory environments for cannabis use.
The Spanish Observatory of Medicinal Cannabis has called on the government to stop seizures of CBD oil in Spain, and demanded clear regulation of cannabis-based products
Executive summary Canada is the centre for the world’s largest cannabis companies and has recently implemented a wide-ranging new regulatory environment for all cannabis products. However, the new cannabis legislation treats CBD in exactly the same way as THC-containing products. Under the Cannabis Act Only licence holders will be allowed to […]
In this overview of Swiss CBD regulation, we find that THC content is limited to 0.3% in cannabis plants and 1% in finished products, significantly higher than most neighbouring countries
Prospects for CBD in Brazil depend hugely on the outcome of the forthcoming presidential election, in which the far right-wing candidate Jair Bolsonaro has emerged as a very strong favourite
A recent judgement by the Constitutional Court of South Africa which legalised the personal use of cannabis in private may not have a big impact on the CBD market in the country
A deadline for the federal legislature to pass a bill expected to remove hemp and low-THC cannabis from the federal list of narcotics lapsed on 30th September, leaving US hemp farmers in regulatory uncertainty
Language in the Senate version of the 2018 US Farm Bill could lead to sweeping changes in the CBD sector – and significant bipartisan support appears to exist to pass it after the November mid-term elections
Cannabis growers in Massachusetts have indicated they may sue the state’s Cannabis Control Commission over a dispute that appears to have delayed the start of legal sales there
CBD should not be scheduled within international drug control conventions, according to the latest meeting of the World Health Organization’s Expert Committee on Drug Dependence
Judicial bodies in France have issued statements clarifying the national legal framework for products containing cannabidiol (CBD) and asked local enforcement authorities to ensure compliance with current legislation
CBD-Intel drops in on a heated meeting of French CBD entrepreneurs, under growing pressure from a government apparently committed to throttling a young industry at birth
US government agencies have questioned the legality of cannabidiol (CBD) – just as the industry is starting to benefit from increased public awareness
E-cigarette firms who already have devices on the market are manoeuvring to see how their products can serve the growing marijuana industry – and they face competition there from some well-financed start-ups.
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields
Notifications
